Filana Therapeutics
FLNA
31 hedge funds and large institutions have $24.2M invested in Filana Therapeutics in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 3 closing their positions.
997% more capital invested
Capital invested by funds: $2.21M → $24.2M (+$22M)
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
35% more funds holding
Funds holding: 23 → 31 (+8)
16.08% more ownership
Funds ownership: 10.6% → 26.68% (+16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$781K |
| 2 |
Renaissance Technologies
New York
|
+$283K |
| 3 |
BlackRock
New York
|
+$168K |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$162K |
| 5 |
Two Sigma Investments
New York
|
+$138K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$220K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
-$29K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$8.11K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.7K |
FLNA Hedge Fund Activity: Q4 2019 in Review
31 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2019, worth a combined $24.2M — up 997% from $2.21M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new FLNA positions and 3 closed out — a net gain of 8 holders — while 9 added to existing stakes and 5 trimmed.
The largest buyer was CVI Holdings, opening a new position worth an estimated $781K. The largest seller was Worth Venture Partners, cutting an estimated $220K.
- 31 institutional investors held Filana Therapeutics (FLNA) as of Q4 2019, up from 23 in Q3 2019.
- Funds reported $24.2M of Filana Therapeutics stock for Q4 2019, up 997% quarter-over-quarter.
- 11 funds opened new Filana Therapeutics positions in Q4 2019 and 3 closed out, a net change of +8 holders.
- The largest Filana Therapeutics buyer in Q4 2019 was CVI Holdings, an estimated $781K added.
- The largest Filana Therapeutics seller in Q4 2019 was Worth Venture Partners, an estimated $220K sold.
Based on aggregated 13F filings for Q4 2019.